164 related articles for article (PubMed ID: 1312129)
1. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
Bolwell C; Parry NR; Rowlands DJ
J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
[TBL] [Abstract][Full Text] [Related]
2. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
4. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
5. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.
Doel TR; Gale C; Do Amaral CM; Mulcahy G; Dimarchi R
J Virol; 1990 May; 64(5):2260-4. PubMed ID: 2157884
[TBL] [Abstract][Full Text] [Related]
6. Multiple variants in foot-and-mouse disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines?
Barteling SJ; Woortmeyer R
Dev Biol Stand; 1987; 66():511-21. PubMed ID: 3034708
[TBL] [Abstract][Full Text] [Related]
7. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
[TBL] [Abstract][Full Text] [Related]
8. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
10. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
[TBL] [Abstract][Full Text] [Related]
12. [Protection from foot-and-mouth disease virus in naturally-susceptible animals by a linear polymer of a synthetic peptide].
Pavlov AV; Rybakov SS; Ivaniushchenkov VN; Chepurkin AV; Petrov VN; Driagalin NN; Burdov AN
Bioorg Khim; 1991 Jul; 17(7):953-63. PubMed ID: 1665331
[TBL] [Abstract][Full Text] [Related]
13. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
[TBL] [Abstract][Full Text] [Related]
14. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
15. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
Morgan DO; Moore DM
Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
[TBL] [Abstract][Full Text] [Related]
16. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
[TBL] [Abstract][Full Text] [Related]
17. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
18. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
19. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
20. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
